论文部分内容阅读
心痛定(nifedipine)是一种钙离子慢通道拮抗剂,Walter(1984)首次将心痛定用于妊高征,经26例次临床观察降压效果明显。本院从1983年11月至1986年7月,对住院的208例妊高征病人用心痛定等药物治疗,观察用药前后多项临床及生化指标,发现心痛定+低分子右旋糖酐(简称ND组)治疗的166例,降压效果明显优于硫酸镁低分子右旋糖酐(简称MD组)治疗的42例,分析如下。资料来源及方法一、资料来源本院从1983年11月至1986年7月,将妊高征病人收入高危病房,设计了ND和MD两组治疗方案。起初半年,用抽签方式决定病人治疗方案,后因病人乐
Nifedipine is a slow release of calcium channel blocker. Walter (1984) first used nifedipine in pregnancy-induced hypertension (PIH). The antihypertensive effect was obvious after 26 times clinical observation. The hospital from November 1983 to July 1986, 208 cases of PIH patients in hospitalized heart pain and other drugs, observed before and after treatment of a number of clinical and biochemical indicators, found that nifedipine + low molecular weight dextran (referred to as ND group ) Treatment of 166 cases, antihypertensive effect was significantly better than magnesium sulfate low molecular weight dextran (MD group) treatment of 42 cases, the analysis is as follows. DATA SOURCES AND METHODS I. DATA SOURCES From November 1983 to July 1986, our hospital recruited patients with PIH to high-risk wards and designed both ND and MD treatment regimens. In the first half of the year, the patient’s treatment plan was decided by drawing lots, and the patients were happy afterwards